Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for insulin resistance in refractory bipolar disorder
NCT02519543Phase 3Completed
- Start
- Sep 2015
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of metformin in bipolar disorder (BD). Started Sep 2015; status: completed.
02
Drugs
metformin
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02519543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02519543.